guidelines:
  1: Multiple_Myeloma_Response_Criteria.v0
test_cases:
- id: Test default action
  input:
    1: {}
  expected_output:
    1:
      gt0018|Diagnostic result: Stable disease
- id: Test criteria for 'Complete response'
  input:
    1:
      ? gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow
      : local::at0005|Yes|
      ? gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence
      : local::at0009|No|
      ? gt0005|Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs
      : local::at0012|No|
      ? gt0006|≥50% reduction of serum M protein and reduction in 24 hr urinary M protein by ≥90% or to <200 mg per 24 hrs; if present at baseline, ≥50% reduction in the size of soft tissue plasmacytomas is also required
      : local::at0014|Yes|
      gt0007|Serum M component: 0|local::at0018|No|
      gt0008|Urine M component: 1|local::at0022|Yes|
      ? 'gt0009|Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels'
      : 0|local::at0024|No|
      gt0010|Bone marrow plasma cell percentage: 0|local::at0027|No|
      ? gt0011|Definite development of new bone lesions or soft tissue plasmacytomas or definite increase in the size of existing bone lesions or soft tissue plasmacytomas
      : 0|local::at0030|No|
      gt0012|Development of hypercalcemia that can be attributed solely to the plasma cell proliferative disorder: 0|local::at0033|No|
  expected_output:
    1:
      gt0014|Total score: 1
      gt0018|Diagnostic result: Complete response
- id: Test criteria for 'Stringent complete response'
  input:
    1:
      ? gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow
      : local::at0006|No|
      ? gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence
      : local::at0008|Yes|
      ? gt0005|Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs
      : local::at0012|No|
      ? gt0006|≥50% reduction of serum M protein and reduction in 24 hr urinary M protein by ≥90% or to <200 mg per 24 hrs; if present at baseline, ≥50% reduction in the size of soft tissue plasmacytomas is also required
      : local::at0014|Yes|
      gt0007|Serum M component: 0|local::at0018|No|
      gt0008|Urine M component: 1|local::at0022|Yes|
      ? 'gt0009|Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels'
      : 0|local::at0024|No|
      gt0010|Bone marrow plasma cell percentage: 0|local::at0027|No|
      ? gt0011|Definite development of new bone lesions or soft tissue plasmacytomas or definite increase in the size of existing bone lesions or soft tissue plasmacytomas
      : 0|local::at0030|No|
      gt0012|Development of hypercalcemia that can be attributed solely to the plasma cell proliferative disorder: 0|local::at0033|No|
  expected_output:
    1:
      gt0014|Total score: 1
      gt0018|Diagnostic result: Stringent complete response
- id: Test criteria for 'Very good partial response'
  input:
    1:
      ? gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow
      : local::at0006|No|
      ? gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence
      : local::at0009|No|
      ? gt0005|Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs
      : local::at0011|Yes|
      ? gt0006|≥50% reduction of serum M protein and reduction in 24 hr urinary M protein by ≥90% or to <200 mg per 24 hrs; if present at baseline, ≥50% reduction in the size of soft tissue plasmacytomas is also required
      : local::at0014|Yes|
      gt0007|Serum M component: 0|local::at0018|No|
      gt0008|Urine M component: 1|local::at0022|Yes|
      ? 'gt0009|Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels'
      : 0|local::at0024|No|
      gt0010|Bone marrow plasma cell percentage: 0|local::at0027|No|
      ? gt0011|Definite development of new bone lesions or soft tissue plasmacytomas or definite increase in the size of existing bone lesions or soft tissue plasmacytomas
      : 0|local::at0030|No|
      gt0012|Development of hypercalcemia that can be attributed solely to the plasma cell proliferative disorder: 0|local::at0033|No|
  expected_output:
    1:
      gt0014|Total score: 1
      gt0018|Diagnostic result: Very good partial response
- id: Test criteria for 'Partial response'
  input:
    1:
      ? gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow
      : local::at0006|No|
      ? gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence
      : local::at0009|No|
      ? gt0005|Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs
      : local::at0012|No|
      ? gt0006|≥50% reduction of serum M protein and reduction in 24 hr urinary M protein by ≥90% or to <200 mg per 24 hrs; if present at baseline, ≥50% reduction in the size of soft tissue plasmacytomas is also required
      : local::at0014|Yes|
      gt0007|Serum M component: 0|local::at0018|No|
      gt0008|Urine M component: 1|local::at0022|Yes|
      ? 'gt0009|Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels'
      : 0|local::at0024|No|
      gt0010|Bone marrow plasma cell percentage: 0|local::at0027|No|
      ? gt0011|Definite development of new bone lesions or soft tissue plasmacytomas or definite increase in the size of existing bone lesions or soft tissue plasmacytomas
      : 0|local::at0030|No|
      gt0012|Development of hypercalcemia that can be attributed solely to the plasma cell proliferative disorder: 0|local::at0033|No|
  expected_output:
    1:
      gt0014|Total score: 1
      gt0018|Diagnostic result: Partial response
- id: Test criteria for 'Progressive disease'
  input:
    1:
      ? gt0003|Negative immunofixation of serum and urine AND disappearance of any soft tissue plasmacytomas AND <5% plasma cells in bone marrow
      : local::at0006|No|
      ? gt0004|Criteria above plus normal FLC ratio (0.26-1.65) AND absence of clonal cells in bone marrow by immunohistochemistry or immunofluorescence
      : local::at0009|No|
      ? gt0005|Serum and urine M component detectable by immunofixation but not on electrophoresis OR ≥90% reduction in serum M component plus urine M component <100 mg per 24 hrs
      : local::at0012|No|
      ? gt0006|≥50% reduction of serum M protein and reduction in 24 hr urinary M protein by ≥90% or to <200 mg per 24 hrs; if present at baseline, ≥50% reduction in the size of soft tissue plasmacytomas is also required
      : local::at0015|No|
      gt0007|Serum M component: 0|local::at0018|No|
      gt0008|Urine M component: 1|local::at0022|Yes|
      ? 'gt0009|Only in patients without measurable serum and urine M protein levels: difference between involved and uninvolved FLC levels'
      : 0|local::at0024|No|
      gt0010|Bone marrow plasma cell percentage: 0|local::at0027|No|
      ? gt0011|Definite development of new bone lesions or soft tissue plasmacytomas or definite increase in the size of existing bone lesions or soft tissue plasmacytomas
      : 0|local::at0030|No|
      gt0012|Development of hypercalcemia that can be attributed solely to the plasma cell proliferative disorder: 0|local::at0033|No|
  expected_output:
    1:
      gt0014|Total score: 1
      gt0018|Diagnostic result: Progressive disease
